RAC-(4S,5S,6R)-6-(BUT-3-EN-1-YL)-4-[DIMETHYL-(PHENYL)-SILYL]-6-HYDROXY-2-OXASPIRO-[4.4]-NONAN-1-ONE
Compound with spectra: 1 NMR
![RAC-(4S,5S,6R)-6-(BUT-3-EN-1-YL)-4-[DIMETHYL-(PHENYL)-SILYL]-6-HYDROXY-2-OXASPIRO-[4.4]-NONAN-1-ONE](/api/compound/8AZe1EodTjg.png?ph=true&h=300&w=458 "RAC-(4S,5S,6R)-6-(BUT-3-EN-1-YL)-4-[DIMETHYL-(PHENYL)-SILYL]-6-HYDROXY-2-OXASPIRO-[4.4]-NONAN-1-ONE")
| SpectraBase Compound ID | 8AZe1EodTjg |
|---|---|
| InChI | InChI=1S/C20H28O3Si/c1-4-5-12-19(22)13-9-14-20(19)17(15-23-18(20)21)24(2,3)16-10-7-6-8-11-16/h4,6-8,10-11,17,22H,1,5,9,12-15H2,2-3H3/t17-,19+,20-/m1/s1 |
| InChIKey | ZUWCTTUKRCLBSD-YZGWKJHDSA-N |
| Mol Weight | 344.53 g/mol |
| Molecular Formula | C20H28O3Si |
| Exact Mass | 344.180771 g/mol |
| Enantiomer InChIKey | ZUWCTTUKRCLBSD-SXLOBPIMSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
RAC-(4R,5S,6S)-4-[DIMETHYL-(PHENYL)-SILYL]-6-HYDROXY-6-(PENT-4-EN-1-YL)-2-OXASPIRO-[4.4]-NONAN-1-ONE
RAC-METHYL-4-[(4R,5S,6R)-4-[DIMETHYL-(PHENYL)-SILYL]-6-HYDROXY-1-OXO-2-OXASPIRO-[4.4]-NONAN-6-YL]-BUTANOATE
RAC-(4R,5R,6S)-6-ETHYL-6-HYDROXY-4-[DIMETHYL-(PHENYL)-SILYL]-2-OXA-SPIRO-[4.4]-NONAN-1-ONE
5-Bromo-1-methyl-4,6-dinitroindoline-2,3-dione
SUPINAIONOSIDE-A;(1S,3S,5R,6R)-MEGASTIGMAN-3-OL-9-ON-12(5)-OLIDE-BETA-D-GLUCOPYRANOSIDE
(4E)-2-(1,3-benzothiazol-2-yl)-4-[[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]methylene]-5-(trifluoromethyl)-2-pyrazolin-3-one
DRYOFRAGIN
19-BUTYRYLOXY-8-BETA-HYDROXY-15-ISOPIMARENE
1-Ethyl-6-fluoro-7-[(4-methylpiperazine)(cyclopentyl)methyleneamino]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
(1RS,2SR,7RS,8RS,9SR)-1-hydroxy-9-hydroxycarbonyl-8-methyltricyclo[7.3.0(2,7).0(1,9)]dodecane
| Title | Journal or Book | Year |
|---|---|---|
| Development of an additive-controlled, SmI2-mediated stereoselective sequence: Telescoped spirocyclisation, lactone reduction and Peterson elimination | Beilstein Journal of Organic Chemistry | 2013 |